![Vorschaubild von Quartalsmitteilung 2024/25 Q3]({"max":"/content/dam/med-ag/investor-relations/financial-publications/afx_quartalsmitteilung_9m202425.pdf/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Quartalsmitteilung 2024/25 Q3")
![Vorschaubild von Halbjahresbericht 2024/25]({"max":"/content/dam/med-ag/investor-relations/financial-publications/afx_quartalsbericht_6m2425.pdf/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Halbjahresbericht 2024/25")
![Vorschaubild von Quartalsmitteilung 2024/25 Q1]({"max":"/content/dam/med-ag/investor-relations/financial-publications/afx_quartalsmitteilung_3m202425.pdf/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Quartalsmitteilung 2024/25 Q1")
![Vorschaubild von Geschäftsbericht 2024/25]({"max":"/content/dam/med-ag/investor-relations/financial-publications/afx_geschaeftsbericht_202425.pdf/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Geschäftsbericht 2024/25")
![Vorschaubild von Jahresabschluss HGB 2024/25]({"max":"/content/dam/med-ag/investor-relations/financial-publications/afx_jahresabschluss_hgb_2425.pdf/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Jahresabschluss HGB 2024/25")
![Vorschaubild von Nichtfinanzieller Bericht 2024/25]({"max":"/content/dam/med-ag/investor-relations/financial-publications/afx_nicht-finanzieller_bericht_2425.pdf/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Nichtfinanzieller Bericht 2024/25")
![Vorschaubild von Konzern Gesamtergebnisrechnung{(/)}2024/25]({"max":"/content/dam/med-ag/investor-relations/financial-publications/2_konzern_gesamtergebnisrechnung_2425.xlsx/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Konzern Gesamtergebnisrechnung{(/)}2024/25")
![Vorschaubild von Konzern GuV 2024/25]({"max":"/content/dam/med-ag/investor-relations/financial-publications/3_konzern_guv_2425.xlsx/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Konzern GuV 2024/25")
![Vorschaubild von Konzernbilanz 2024/25]({"max":"/content/dam/med-ag/investor-relations/financial-publications/4_konzernbilanz_2425.xlsx/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Konzernbilanz 2024/25")
![Vorschaubild von Konzernkapitalflussrechnung 2024/25]({"max":"/content/dam/med-ag/investor-relations/financial-publications/5_konzernkapitalflussrechnung_2425.xlsx/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Konzernkapitalflussrechnung 2024/25")
![Vorschaubild von Konzern Gesamtergebnisrechnung {(/)}6M 2024/25]({"max":"/content/dam/med-ag/investor-relations/financial-publications/de_gesamtergebnisrechnung_310325.xlsx/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Konzern Gesamtergebnisrechnung {(/)}6M 2024/25")
![Vorschaubild von Konzern GuV 6M 2024/25]({"max":"/content/dam/med-ag/investor-relations/financial-publications/de_gewinn-und-verlustrechnung_310325.xlsx/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Konzern GuV 6M 2024/25")
![Vorschaubild von Konzernbilanz 6M 2024/25]({"max":"/content/dam/med-ag/investor-relations/financial-publications/de_konzernbilanz_310325.xlsx/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Konzernbilanz 6M 2024/25")
![Vorschaubild von Konzernkapitalflussrechnung 6M 2024/25]({"max":"/content/dam/med-ag/investor-relations/financial-publications/de_kapitaflussrechnung_310325.xlsx/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Konzernkapitalflussrechnung 6M 2024/25")
![Vorschaubild von Konzern Gesamtergebnisrechnung 2023/24]({"max":"/content/dam/med-ag/investor-relations/financial-publications/2_konzern_gesamtergebnisrechnung_2324.xlsx/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Konzern Gesamtergebnisrechnung 2023/24")
![Vorschaubild von Konzern GuV 2023/24]({"max":"/content/dam/med-ag/investor-relations/financial-publications/3_konzern_guv_2324.xlsx/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Konzern GuV 2023/24")
![Vorschaubild von Konzernbilanz 2023/24]({"max":"/content/dam/med-ag/investor-relations/financial-publications/4_konzernbilanz_2324.xlsx/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Konzernbilanz 2023/24")
![Vorschaubild von Konzernkapitalflussrechnung 2023/24]({"max":"/content/dam/med-ag/investor-relations/financial-publications/5_konzernkapitalflussrechnung_2324.xlsx/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Konzernkapitalflussrechnung 2023/24")
|
2024/25
|
2023/24
|
2022/23
|
||||
|---|---|---|---|---|---|---|
|
|
Mio. € |
% |
Mio. € |
% |
Mio. € |
% |
|
Umsatz |
2.227,6 |
100 |
2.066,1 |
100 |
2.089,3 |
100 |
|
Forschungs- und Entwicklungskosten |
326,3 |
14,6 |
343,1 |
16,6 |
349,3 |
16,7 |
EBITA1 |
257,7
|
11,6 |
248,9 |
12,0 |
358,6 |
17,2 |
Konzernergebnis |
142,3 |
6,3 |
180,2 |
8,7 |
292,0 |
14,0 |
|
Ergebnis je Aktie |
1,61 |
2,01 |
3,25 |
|||
|
Dividende je Aktie2 |
0,55 |
0,60 |
1,10 |
|||
|
|
||||||
|
Cash flow aus der betrieblichen Geschäftstätigkeit |
209,9 |
247,3 |
250,9 |
|||
Cashflow aus der Investitionstätigkeit
|
-91,0 |
-412,3 |
-111,0 |
|||
|
Cashflow aus der Finanzierungstätigkeit |
-108,8 |
176,2 |
-135,1 |
|||
|
|
||||||
|
|
30.9.2025 |
30.9.2024 |
30.9.2023 |
|||
Bilanzsumme
|
3.403,4 |
100 |
3.393,2 |
100 |
3.032,9 |
100 |
|
Sachanlagen |
343,0 |
10,1 |
353,8 |
10,4 |
315,8 |
10,4 |
|
Eigenkapital |
2.127,7 |
62,5 |
2.056,5 |
60,6 |
2.172,9 |
71,6 |
|
Nettofinanzverschuldung3 |
-276,9 |
-327,4 |
863,8 |
|||
|
|
||||||
|
|
30.9.2025 |
30.9.2024 |
30.9.2023 |
|||
|
Eigenkapitalrendite |
|
6,6 |
|
8,7 |
|
13,4 |
|
|
||||||
|
|
30.9.2025 |
30.9.2024 |
30.9.2023 |
|||
|
Mitarbeitende (Anzahl) |
5.784 |
5.726 |
4.823 |
|||
![]({"xsmall":"https://www.zeiss.com/content/dam/med-ag/investor-relations/screenshot.png/_jcr_content/renditions/original.image_file.100.33.0,80,1684,641.file/screenshot.png","small":"https://www.zeiss.com/content/dam/med-ag/investor-relations/screenshot.png/_jcr_content/renditions/original.image_file.360.120.0,80,1684,641.file/screenshot.png","medium":"https://www.zeiss.com/content/dam/med-ag/investor-relations/screenshot.png/_jcr_content/renditions/original.image_file.768.256.0,80,1684,641.file/screenshot.png","large":"https://www.zeiss.com/content/dam/med-ag/investor-relations/screenshot.png/_jcr_content/renditions/original.image_file.1024.341.0,80,1684,641.file/screenshot.png","xlarge":"https://www.zeiss.com/content/dam/med-ag/investor-relations/screenshot.png/_jcr_content/renditions/original.image_file.1280.427.0,80,1684,641.file/screenshot.png","xxlarge":"https://www.zeiss.com/content/dam/med-ag/investor-relations/screenshot.png/_jcr_content/renditions/original.image_file.1440.480.0,80,1684,641.file/screenshot.png","max":"https://www.zeiss.com/content/dam/med-ag/investor-relations/screenshot.png/_jcr_content/renditions/original.image_file.1684.561.0,80,1684,641.file/screenshot.png"})
GESCHÄFTSBERICHT 2024/25
Expanding Markets.
Transforming HealthcareFinanzpublikationen
Neue Produkte sind der Schlüssel zum Erfolg unseres Unternehmens. Diese Innovationsstärke ist die Triebkraft für unser Wachstum. In diesem Bereich zeigen wir Ihnen Fakten und Zahlen zur Finanzlage des Unternehmens.Downloads
Finanzkennzahlen
![]({"xsmall":"https://www.zeiss.com/content/dam/med-ag/investor-relations/financial-calendar/ipad_annual_general_meeting_980x308.jpg/_jcr_content/renditions/original.image_file.100.56.216,0,764,308.file/ipad_annual_general_meeting_980x308.jpg","small":"https://www.zeiss.com/content/dam/med-ag/investor-relations/financial-calendar/ipad_annual_general_meeting_980x308.jpg/_jcr_content/renditions/original.image_file.360.203.216,0,764,308.file/ipad_annual_general_meeting_980x308.jpg","medium":"https://www.zeiss.com/content/dam/med-ag/investor-relations/financial-calendar/ipad_annual_general_meeting_980x308.jpg/_jcr_content/renditions/original.image_file.548.308.216,0,764,308.file/ipad_annual_general_meeting_980x308.jpg","large":"https://www.zeiss.com/content/dam/med-ag/investor-relations/financial-calendar/ipad_annual_general_meeting_980x308.jpg/_jcr_content/renditions/original.image_file.548.308.216,0,764,308.file/ipad_annual_general_meeting_980x308.jpg","xlarge":"https://www.zeiss.com/content/dam/med-ag/investor-relations/financial-calendar/ipad_annual_general_meeting_980x308.jpg/_jcr_content/renditions/original.image_file.548.308.216,0,764,308.file/ipad_annual_general_meeting_980x308.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-ag/investor-relations/financial-calendar/ipad_annual_general_meeting_980x308.jpg/_jcr_content/renditions/original.image_file.548.308.216,0,764,308.file/ipad_annual_general_meeting_980x308.jpg","max":"https://www.zeiss.com/content/dam/med-ag/investor-relations/financial-calendar/ipad_annual_general_meeting_980x308.jpg/_jcr_content/renditions/original.image_file.548.308.216,0,764,308.file/ipad_annual_general_meeting_980x308.jpg"})
![]({"xsmall":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/searching_of_documents_bunt_980x308.jpg/_jcr_content/renditions/original.image_file.100.56.216,0,764,308.file/searching_of_documents_bunt_980x308.jpg","small":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/searching_of_documents_bunt_980x308.jpg/_jcr_content/renditions/original.image_file.360.203.216,0,764,308.file/searching_of_documents_bunt_980x308.jpg","medium":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/searching_of_documents_bunt_980x308.jpg/_jcr_content/renditions/original.image_file.548.308.216,0,764,308.file/searching_of_documents_bunt_980x308.jpg","large":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/searching_of_documents_bunt_980x308.jpg/_jcr_content/renditions/original.image_file.548.308.216,0,764,308.file/searching_of_documents_bunt_980x308.jpg","xlarge":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/searching_of_documents_bunt_980x308.jpg/_jcr_content/renditions/original.image_file.548.308.216,0,764,308.file/searching_of_documents_bunt_980x308.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/searching_of_documents_bunt_980x308.jpg/_jcr_content/renditions/original.image_file.548.308.216,0,764,308.file/searching_of_documents_bunt_980x308.jpg","max":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/searching_of_documents_bunt_980x308.jpg/_jcr_content/renditions/original.image_file.548.308.216,0,764,308.file/searching_of_documents_bunt_980x308.jpg"})
![]({"xsmall":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/archive.jpg/_jcr_content/renditions/original.image_file.100.56.1,0,1765,992.file/archive.jpg","small":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/archive.jpg/_jcr_content/renditions/original.image_file.360.203.1,0,1765,992.file/archive.jpg","medium":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/archive.jpg/_jcr_content/renditions/original.image_file.768.432.1,0,1765,992.file/archive.jpg","large":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/archive.jpg/_jcr_content/renditions/original.image_file.1024.576.1,0,1765,992.file/archive.jpg","xlarge":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/archive.jpg/_jcr_content/renditions/original.image_file.1280.720.1,0,1765,992.file/archive.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/archive.jpg/_jcr_content/renditions/original.image_file.1440.810.1,0,1765,992.file/archive.jpg","max":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/archive.jpg/_jcr_content/renditions/original.image_file.1764.992.1,0,1765,992.file/archive.jpg"})
Anlegerinformation anfordern
-
1
Ergebnis vor Zinsen, Steuern und Abschreibungen aus Kaufpreisallokationen auf immaterielle Vermögenswerte
-
2
Höhe gem. Vorschlag des Aufsichtsrats und des Vorstands der Carl Zeiss Meditec AG
-
3
Das Geschäftsjahr 2022/23 zeigt die Nettoliquidität (Zahlungsmittel- und äquivalente zzgl. Forderungen / Verbindlichkeiten gegenüber dem Treasury der Carl Zeiss AG)